Dear Editor,rnThe ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has resulted in an unprecedented public health crisis,galvanizing a global effort for rapidly developing new therapeutic strategies effective against COVID-19.Human monoclonal anti-bodies (mAbs) are promising therapeutic molecules that can be used for the prevention or treatment of viral infectious diseases,including COVID-19.